<code id='0F7DFC448E'></code><style id='0F7DFC448E'></style>
    • <acronym id='0F7DFC448E'></acronym>
      <center id='0F7DFC448E'><center id='0F7DFC448E'><tfoot id='0F7DFC448E'></tfoot></center><abbr id='0F7DFC448E'><dir id='0F7DFC448E'><tfoot id='0F7DFC448E'></tfoot><noframes id='0F7DFC448E'>

    • <optgroup id='0F7DFC448E'><strike id='0F7DFC448E'><sup id='0F7DFC448E'></sup></strike><code id='0F7DFC448E'></code></optgroup>
        1. <b id='0F7DFC448E'><label id='0F7DFC448E'><select id='0F7DFC448E'><dt id='0F7DFC448E'><span id='0F7DFC448E'></span></dt></select></label></b><u id='0F7DFC448E'></u>
          <i id='0F7DFC448E'><strike id='0F7DFC448E'><tt id='0F7DFC448E'><pre id='0F7DFC448E'></pre></tt></strike></i>

          fashion

          fashion

          author:knowledge    Page View:953

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Stem cell treatment guidelines are released by FDA
          Stem cell treatment guidelines are released by FDA

          HumanembryonicstemcellsAnnieCavanagh/WellcomeImagesTheFoodandDrugAdministrationonThursdayunveiledase

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Why Novartis is changing the name of its research labs

          FionaMarshall,presidentoftheNovartisresearchhubinCambridge,Mass.,speaksThursdayduringtheSTATFutureSu